NCT02689102

Brief Summary

Often, assessing a classifying diagnosis in patients with interstitial lung disease provides a diagnostic challenge. Currently HRCT, endoscopic or surgical video assisted thoracoscopic surgery(VATS) assessment including lung biopsies are diagnostic tools for patients with suspected ILD. However, tissue acquisition is associated with morbidity in these patients with an already compromised pulmonary function. In clinical practice this results in the fact that only a minor part of patients with an indication for tissue acquisition are actually undergoing biopsies. The aim of this study is to determine ILD-characteristics on imagign collected with minimal invasive novel optical techniques, to examine whether the addition of novel optical techniques to the diagnostic process of ILD could potentially limit the need for a tissue- (surgical) diagnosis and/or reduce the sampling error rate of biopsies by providing additional information on biopsy location.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 28, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2016

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 23, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2017

Completed
Last Updated

September 20, 2017

Status Verified

September 1, 2017

Enrollment Period

1.5 years

First QC Date

January 28, 2016

Last Update Submit

September 19, 2017

Conditions

Keywords

Optical coherence tomographyConfocal laser endomicroscopy

Outcome Measures

Primary Outcomes (1)

  • Describing visual characteristics on CLE-imaging and pOCT imaging of ILD.

    cross sectional (1 day)

Secondary Outcomes (5)

  • (um), size of the alveolar openings, number of cells on CLE imaging of the alveolar space (um).

    cross-sectional (1 day)

  • Size of the alveolar openings (um), thickness of the alveolar septum/alveolar openings on pOCT imaging of the alveolar compartment (um).

    cross-sectional (1day)

  • Feasibility of pOCT alveolar compartment: measuring number of alveoli, trajectory in OCT pull-back with alveoli (mm), number of study-related adverse events.

    cross-sectional (1 day)

  • Correlation between pOCT imaging and histology (alveolar septum-thickness and alveolar space (um))

    cross-sectional (1 day)

  • Correlation between pOCT imaging and histology (alveolar septum thickness (um) and alveolar compartment (mm)

    cross-sectional (1 day)

Study Arms (1)

ILD patients

ILD patients scheduled for diagnostic bronchoscopy with biopsy and/or broncho-alveolar lavage will undergo additional imagaing with probe based optical techniques.

Device: Probe based optical techniques

Interventions

During the diagnostic bronchoscopy, optical biopsy of the mucosa and alveolar compartment will be conducted by two different probe based optical techniques (Confocal Laser Endomicroscopy (Mauna Kea technologies) and Optical Coherence Tomography (St Jude Medical)). After the study measurements a biopsy will be obtained in the same area.

Also known as: Confocal Laser Endomicroscopy (Mauna Kea technologies), Optical Coherence Tomography (St Jude medical)
ILD patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of 18 years or older (n=20), who are suspected for ILD based on imaging (HRCT-scan) and with an indication for bronchoscopy with cryobiopsy.

You may qualify if:

  • years of age
  • Supected ILD and referred for diagnostic bronchoscopic procedure with cryobiopsy

You may not qualify if:

  • Smoked in the last 6 months
  • Inability and willingness to provide informed consent
  • Inability to comply with the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academisch Medisch Centrum

Amsterdam, North Holland, 1105 AZ, Netherlands

Location

MeSH Terms

Conditions

Lung Diseases, Interstitial

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Jouke T Annema, MD, PhD

    Netherlands, Academisch Medisch Centrum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof.dr. J.T. Annema

Study Record Dates

First Submitted

January 28, 2016

First Posted

February 23, 2016

Study Start

October 28, 2015

Primary Completion

April 22, 2017

Study Completion

April 22, 2017

Last Updated

September 20, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will share

CLE and OCT imaging

Locations